Opus Genetics Statistics
NASDAQ: IRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.41+0.03 (+0.68%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Opus Genetics by the numbers
Opus Genetics has a market capitalization of $366.9 million based on 83.20M shares outstanding. With trailing EPS of $-1.27, Opus Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.6% above its 50-day average and 10.0% above its 200-day average.
Average daily trading volume is 2.35M shares, or about $10.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IRD valuation vs. peer median
| Metric | IRD | Peer median | Difference |
|---|---|---|---|
| Market cap | $366.89M | $362.66M | +1% |
| Avg. volume | 2.35M | 666.59K | +253% |
Peer median across 8 companies: GALT, ARCT, EBS, TTRX, ENTA, RLMD, CYPH, AVIR.
Valuation
- Market cap
- $366.89M
- EPS (TTM)
- $-1.27
- Shares outstanding
- 83.20M
Price and trading
- Previous close
- 4.38
- Open
- 4.32
- Day range
- 4.25 – 4.66
- 52-week range
- 1.70 – 7.07
- 52-week change
- +117.24%
- Beta
- —
- Volume
- 1.84M
- Average volume
- 2.35M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 366.89M
- Forward Pe
- -6.17
- Eps
- -1.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.07
- Week52 Low
- 1.70
- Avg Volume
- 2.35M
- Shares Outstanding
- 83.20M
- Ma50
- 4.38
- Ma200
- 4.01
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -37.62%
- Pct From52w Low
- 159.41%